These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4812469)

  • 1. PMA views told Senate Committee.
    J Indiana State Med Assoc; 1974 Feb; 67(2):121. PubMed ID: 4812469
    [No Abstract]   [Full Text] [Related]  

  • 2. PMA views on prescription-size packaging.
    Stetler CJ
    Hosp Formul; 1976 Jun; 11(6):300. PubMed ID: 10236464
    [No Abstract]   [Full Text] [Related]  

  • 3. All may not be meeting the eye.
    Archambault GF
    Hosp Formul; 1975 Aug; 10(8):414. PubMed ID: 10237848
    [No Abstract]   [Full Text] [Related]  

  • 4. The brand name system--an intrusion upon the profession.
    Feldmann EG
    J Am Pharm Assoc; 1971 Jul; 11(7):376-9 passim. PubMed ID: 5142132
    [No Abstract]   [Full Text] [Related]  

  • 5. American Pharmaceutical Association House of Delegates, May 13-18, 1978, Montreal, Quebec, Canada. Report of the Policy Committee on Organizational Affairs.
    Am Pharm; 1978 Jul; 18(8 Spec No):32-5. PubMed ID: 665505
    [No Abstract]   [Full Text] [Related]  

  • 6. Principles of drug-use review approved by APhA, AMA, and PMA.
    Am J Hosp Pharm; 1991 Oct; 48(10):2062. PubMed ID: 1781458
    [No Abstract]   [Full Text] [Related]  

  • 7. 'People want something done about the soaring cost of health care': PMA president.
    Engman LA
    J Indiana State Med Assoc; 1980 Jul; 73(7):476-7. PubMed ID: 7452041
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 9. Veterinary drug availability.
    Gloyd J
    J Am Vet Med Assoc; 1980 Apr; 176(7):611-4. PubMed ID: 7372533
    [No Abstract]   [Full Text] [Related]  

  • 10. Comments on the American Pharmaceutical Association on proposed rulemakings.
    J Am Pharm Assoc; 1975 Mar; 15(3):139-44. PubMed ID: 1092750
    [No Abstract]   [Full Text] [Related]  

  • 11. Standing on your own feet.
    Apple WS
    J Am Pharm Assoc; 1974 Jun; 14(6):278-80. PubMed ID: 4840422
    [No Abstract]   [Full Text] [Related]  

  • 12. ASCP leaders testify before Senate Special Committee on Aging.
    Batshon L
    Consult Pharm; 2010 May; 25(5):326. PubMed ID: 20497931
    [No Abstract]   [Full Text] [Related]  

  • 13. The "Long" amendment.
    Provost GP
    Am J Hosp Pharm; 1967 Dec; 24(12):665. PubMed ID: 6073365
    [No Abstract]   [Full Text] [Related]  

  • 14. APhA testifies on drug regulation bill.
    Am Pharm; 1978 Jun; 18(6):34-6. PubMed ID: 665498
    [No Abstract]   [Full Text] [Related]  

  • 15. Extra-label drug use--pharmaceutical industry view.
    Welser JR
    J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
    [No Abstract]   [Full Text] [Related]  

  • 16. Adoption of orphan products by the pharmaceutical industry.
    Finkel MJ
    N Engl J Med; 1984 Sep; 311(10):677-8. PubMed ID: 6472354
    [No Abstract]   [Full Text] [Related]  

  • 17. APhA government affairs annual report.
    Am Pharm; 1987 Feb; NS27(2):35-8. PubMed ID: 3565249
    [No Abstract]   [Full Text] [Related]  

  • 18. Statement of the APhA to the Subcommittee on Health United States Senate. 93rd Congress, 2nd session, Washington, D.C., July 22, 1974.
    Apple WS
    J Am Pharm Assoc; 1974 Oct; 14(10):572-6. PubMed ID: 4419654
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs and the Washington climate.
    Durant TM
    Trans Am Clin Climatol Assoc; 1969; 80():196-204. PubMed ID: 4896316
    [No Abstract]   [Full Text] [Related]  

  • 20. Producer industry views on the AVMA legislative initiative.
    Keeling J
    J Am Vet Med Assoc; 1993 May; 202(10):1679-80;discussion 1684-92. PubMed ID: 8514583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.